Order Article Reprints

Alshammari GM, Abdelhalim MA, Al-Ayed MS, Al-Harbi LN, Yahya MA. Concomitant Sub-Chronic Administration of Small-Size Gold Nanoparticles Aggravates Doxorubicin-Induced Liver Oxidative and Inflammatory Damage, Hyperlipidemia, and Hepatic Steatosis. Molecules. 2023; 28(2):796. https://doi.org/10.3390/molecules28020796

Alshammari, Ghedeir M., Mohamed Anwar Abdelhalim, Mohammed S. Al-Ayed, Laila Naif Al-Harbi, and Mohammed Abdo Yahya. 2023. "Concomitant Sub-Chronic Administration of Small-Size Gold Nanoparticles Aggravates Doxorubicin-Induced Liver Oxidative and Inflammatory Damage, Hyperlipidemia, and Hepatic Steatosis" Molecules 28, no. 2: 796. https://doi.org/10.3390/molecules28020796

Alshammari, G. M., Abdelhalim, M. A., Al-Ayed, M. S., Al-Harbi, L. N., & Yahya, M. A. (2023). Concomitant Sub-Chronic Administration of Small-Size Gold Nanoparticles Aggravates Doxorubicin-Induced Liver Oxidative and Inflammatory Damage, Hyperlipidemia, and Hepatic Steatosis. Molecules, 28(2), 796. https://doi.org/10.3390/molecules28020796